A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy ; volume:12 ; number:1 ; day:21 ; month:3 ; year:2012 ; pages:1-6 ; date:12.2012
BMC cancer ; 12, Heft 1 (21.3.2012), 1-6, 12.2012
- Creator
-
Lee, C Ellen
- Contributor
-
Leslie, William D.
Lau, YK James
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-12-103
- URN
-
urn:nbn:de:1111-201603041533
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lee, C Ellen
- Leslie, William D.
- Lau, YK James
- SpringerLink (Online service)
Other Objects (12)
Physical exercise for bone health in men with prostate cancer receiving androgen deprivation therapy: a systematic review
Efficacy of walking exercise in promoting cognitive-psychosocial functions in men with prostate cancer receiving androgen deprivation therapy
Risk of ischemic stroke in patients with prostate cancer receiving androgen deprivation therapy in Taiwan
Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
Risk of colorectal adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer; a nationwide cohort study
Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy
Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer
Androgen deprivation in prostate cancer: benefits of home-based resistance training
Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?
Physical exercise for bone health in men with prostate cancer receiving androgen deprivation therapy: a systematic review
Efficacy of walking exercise in promoting cognitive-psychosocial functions in men with prostate cancer receiving androgen deprivation therapy
Risk of ischemic stroke in patients with prostate cancer receiving androgen deprivation therapy in Taiwan
Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
Risk of colorectal adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer; a nationwide cohort study
Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy
Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer
Androgen deprivation in prostate cancer: benefits of home-based resistance training
Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?
Physical exercise for bone health in men with prostate cancer receiving androgen deprivation therapy: a systematic review
Efficacy of walking exercise in promoting cognitive-psychosocial functions in men with prostate cancer receiving androgen deprivation therapy
Risk of ischemic stroke in patients with prostate cancer receiving androgen deprivation therapy in Taiwan
Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
Risk of colorectal adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer; a nationwide cohort study
Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy
Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer
Androgen deprivation in prostate cancer: benefits of home-based resistance training
Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer